KARD

Kardigan, Inc.

Healthcare · Biotechnology

$285.91 sample

+2.68 (+0.95%) 1D

Market cap

$567.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$285.91 +10.88% 3M daily closessample

285.91257.86

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09INSInsider sell: General Counsel
Oct 06SEC8-K filed: material event
Sep 29INSInsider sell: Chief Executive Officer
Sep 21INSInsider sell: Director
Sep 15INSInsider sell: Chief Financial Officer
Sep 08INSInsider sell: Chief Executive Officer
Aug 28INSInsider buy: 10% owner
Aug 19INSInsider sell: General Counsel

Sign up to see the real KARD record →

Company facts

SEC EDGAR registration

Name: Kardigan, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -7sample, -100 to +100
Reporting currency: USD

Who is positioning in KARD

sample

Insiders: 11 insider transactions over 90 days, net selling, $232.9M
Congress: 1 members traded over 90 days
Institutions · 13F: 38 funds hold $6.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.9B +21.2% y/y

Q4 2024Q3 2026

Inventory$12.9B +11.2% y/y

Q4 2024Q3 2026

Accounts receivable$10.1B +8.1% y/y

Q4 2024Q3 2026

Total debt$26.2B +12.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $524.1B +3.8% 3M
Sample peer B: $255.6B -2.7% 3M
Sample peer C: $177.3B +5.5% 3M
Sample peer D: $451.0B -12.4% 3M
Sample peer E: $176.3B +8.0% 3M